226: Pharma's telehealth gold mine, the return of the biotech IPO, & a merger deferred
The Readout Loud
00:00
Introduction
The latest trend in pharmaceutical advertising stretches the definition of ask your doctor if this treatment is right for you. Katie Palmer joins us to explain the controversy over telehealth prescribing. We also discuss the latest news in the life sciences including a bellwether biotech IPO, the cooling of some summer merger rumors and JP Morgan 2023.
Transcript
Play full episode
